The observation that MGMT methylation is more frequent in non-SEs, a subtype that usually presents a more aggressive behavior suggests that alkylating agents (i.e. temozolomide), could be used in the treatment of TGCT. This evidence concerns the gene MGMT and testicular germ cell tumor.